Activity of NRF2-associated antioxidant enzymes is reduced in in vitro models [104]: HO-1 in animal diabetic models [103] and SOD, GR, GPx, and CAT in patients with diabetes [105, 106]. The gene discussed is NFE2L2; the disease is diabetes mellitus.